FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

704314009: Tofacitinib citrate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3012850018 Tofacitinib citrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3012865017 Tofacitinib citrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
846561000172110 citrate de tofacitinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tofacitinib citrate Is a Tofacitinib (substance) false Inferred relationship Some
Tofacitinib citrate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Janus kinase inhibitor (disposition) true Inferred relationship Some
Tofacitinib citrate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Tofacitinib (substance) true Inferred relationship Some
Tofacitinib citrate Is a Janus kinase inhibitor true Inferred relationship Some
Tofacitinib citrate Is a Immunosuppressant (substance) true Inferred relationship Some
Tofacitinib citrate Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Tofacitinib citrate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. A substance that modifies the immune response or the functioning of the immune system. true Inferred relationship Some
Tofacitinib citrate Is a Enzyme inhibitor false Inferred relationship Some
Tofacitinib citrate Is a Nitrile true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely tofacitinib citrate 5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tofacitinib citrate Inferred relationship Some
Product containing precisely tofacitinib citrate 5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Tofacitinib citrate Inferred relationship Some 1
Product containing precisely tofacitinib citrate 5 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Tofacitinib citrate Inferred relationship Some 1
Product containing precisely tofacitinib citrate 5 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Tofacitinib citrate Inferred relationship Some 1
Product containing precisely tofacitinib (as tofacitinib citrate) 5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tofacitinib citrate Inferred relationship Some 1
Product containing precisely tofacitinib (as tofacitinib citrate) 11 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tofacitinib citrate Inferred relationship Some 1
Tofacitinib (as tofacitinib citrate) 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tofacitinib citrate Inferred relationship Some 1
Tofacitinib (as tofacitinib citrate) 1 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Tofacitinib citrate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start